SPEEDX
30.6.2021 10:21:09 CEST | Business Wire | Press release
SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The partnership links specimen handling, nucleic acid extraction, assay set-up, amplification, and results reporting in a seamless integration of the companies technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210630005407/en/
“This partnership capitalises on the existing infrastructure of our two companies and the strength of our synergies,” said Colin Denver, SpeeDx CEO. “Our commitment to providing products and services that answer unmet clinical needs also extends to the pathology laboratories that are running our tests – in partnership with MolGen, we can address much of their workflow concerns and offer a more complete testing solution.”
Throughout the past year of COVID-19, in response to the increased demand for molecular testing workflow solutions, MolGen has developed a comprehensive offering including the PurePrep nucleic acid extraction portfolio, liquid handling instrumentation and other purpose-built automation to facilitate high-volume testing of SARS-CoV-2. SpeeDx complete the partnership with an initial offer of their CE-IVD SARS-CoV-2 test based on their proprietary Plex PCR® technology, allowing pathology laboratories a single point of contact to fulfil their testing needs.
“For MolGen, the collaboration with SpeeDx is a perfect example of combining the best of both worlds. Our DNA and RNA extraction solutions and automated workflow perfectly pair with SpeeDx diagnostic assay technology” said Maarten de Groot, MolGen CEO. “During the COVID pandemic adding the CE-IVD SARS-CoV-2 assay to our diagnostics portfolio is great opportunity to start our collaboration. And this is only the beginning of jointly building an innovative product portfolio”.
About SpeeDx
Founded in 2009, SpeeDx is an Australian-based private company with subsidiary offices in Austin, Texas and London, UK, with distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease. For more information on SpeeDx please see: https://plexpcr.com
About MolGen
MolGen is global total solution provider of innovative extraction DNA / RNA technology, system, products and kits for human and animal diagnostics, the agriculture and biotech industries which reduce hands-on time and increase productivity while maintaining high yields and reproducibility.
From sample to result, MolGen is challenging the status quo in molecular diagnostics by offering platform stand-alone systems and consumables. Highly customizable, MolGen’s portfolio offers the perfect workflow for our customers’ specific needs, being high-quality, adaptable and safe.
Due to travel restrictions Maarten de Groot, MolGen CEO and Colin Denver, SpeeDx CEO joined a virtual session to officially announce the collaboration that will combine Molgen liquid handling and purpose-built automation with SpeeDx COVID-19 diagnostic solutions - extending a full workflow offering to pathology laboratories.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210630005407/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines to Present at Upcoming Investor Conferences17.2.2026 12:00:00 CET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Company will participate in fireside chats at four upcoming investor conferences: TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 at 9:10 am ET; Leerink Global Healthcare Conference on Monday, March 9, 2026 at 11:20 am ET; Citizens Life Sciences Conference on Tuesday, March 10, 2026 at 9:35 am ET; and Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 3:00 pm ET Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel the
CTC Global Launches GridVista System and Strategic Partnership with Google Cloud and Tapestry to Transform Grid Intelligence17.2.2026 12:00:00 CET | Press release
New technology redefines transmission line intelligence, delivering continuous, high-resolution data across the entire length of the transmission line CTC Global, the world’s leading developer and manufacturer of high-capacity advanced conductors, today announced the launch of the GridVista System. The GridVista System provides utilities with real-time, high-resolution data to optimize grid capacity, prevent outages, reduce wildfire risk, and lower operational costs. With the launch of the GridVista System, CTC is also announcing a deepening of its strategic partnership with Google Cloud and Tapestry—Alphabet’s moonshot for the electric grid. GridVista System’s unprecedented line awareness, paired with Google Cloud and Tapestry’s AI-powered tools, will transform line data into actionable intelligence for the grid. The GridVista System redefines transmission line intelligence by utilizing optical fibers embedded directly within CTC Global’s ACCC Conductor. Unlike legacy technology that
Kingspan Insulation Chooses Expereo to Unify Connectivity and Accelerate Growth Across 90 Global Sites17.2.2026 10:00:00 CET | Press release
Partnership follows Expereo’s recent agreement with Kingspan Light, Air + Water to deliver a fully managed connectivity solution for its worldwide operations Expereo, the world-leading managed Network as a Service (NaaS) provider that connects people, places and things anywhere, announces that Kingspan Insulation, the global manufacturer of premium and high-performance insulation products and systems, has selected Expereo to deliver a fully managed connectivity solution across its worldwide operations. Expereo’s solution enables Kingspan Insulation to consolidate its complex network of disparate ISPs into a single, centralised, fully managed solution - enhancing visibility, compliance, and agility to enable rapid growth and scalability of Kingspan Insulation’s operations. Kingspan Insulation manages a complex WAN environment with 90 sites globally across multiple vendors - which creates significant challenges in terms of efficient connectivity, compliance and security. With the busines
Ohana Development Launches USD 4.1 Billion ‘Manchester City Yas Residences by Ohana’ in Abu Dhabi17.2.2026 09:51:00 CET | Press release
Ohana Development, a leading UAE real estate developer, has officially launched ‘Manchester City Yas Residences by Ohana,’ a USD 4.1 billion gated waterfront community on Yas Canal in Abu Dhabi and Manchester City F.C.’s first branded residential project globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260216102386/en/ Manchester City Yas Residences by Ohana (Photo: AETOSWire) The project was launched at Etihad Park in Abu Dhabi, in the presence of Husein Salem, CEO, and Mustafa El Sammak, COO, of Ohana Development as well as Ferran Soriano, CEO of City Football Group. During the event, the Abu Dhabi Real Estate Centre announced the digitisation of Expressions of Interest and booking processes for off-plan purchases through its Madhmoun platform, introducing a new regulated framework in Abu Dhabi. Registrations will operate under ADREC’s direct supervision with mandatory escrow management, strengthening investor prot
ITC Secure and IronNet Unite to Form Collective Defence, a New Force in Critical Infrastructure Protection Against Hybrid Warfare17.2.2026 09:00:00 CET | Press release
Collective Defence brings together world-class cybersecurity and AI capabilities to defend nations and enterprises against state-sponsored and hybrid threats targeting critical infrastructure. Collective Defence today announces its formation following the combination of ITC Secure, a leading UK-based cybersecurity services firm and Microsoft Security Solutions Partner, and IronNet, a pioneer in collective defence and network detection technology. The company is headquartered in Luxembourg and operates from offices in the United States, United Kingdom, and Singapore. Collective Defence addresses one of the most pressing security challenges of our time: the escalating threat of hybrid warfare targeting critical infrastructure. Across energy grids, telecommunications networks, financial systems, healthcare and satellite infrastructure, nation-states and their proxies are conducting persistent, sophisticated campaigns. This blurs the lines between cyber operations, disinformation, and phys
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom